NCT07406087Recruiting
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Adaptation and Implementation of an Evidence-Based Patient Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Source: ClinicalTrials.gov · Last updated 6 Jul 2026
Brief summary (registry, in English)
The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPSC). PLEASE NOTE: This study is awarded in two phases. The UG3 phase has been awarded for the first two years; upon successful completion of this phase by meeting pre-defined milestones, the National Cancer Institute (NCI) will provide funding for the second phase of the study (Years 3-6), which will allow our team to conduct a trial to determine the effectiveness of the implementation of the adapted PN program for the AYA cancer survivor population. This application is focused on the initial UG3 phase and will update the protocol for the UH3 trial upon successful completion of the UG3 milestones and receipt of the UH3 award. The primary objectives in the UG3 phase of the study are to adapt and tailor an existing PN program to meet the needs of AYA cancer survivors and the local clinical context via (a) interviews with key stakeholders (patients, clinicians, administrators) and (b) guidance from our AYA Primary Care Survivorship Council. The investigators will conduct a pilot study of the adapted PN program and refine the program to enhance acceptability to patients and clinicians, enhance feasibility and effectiveness, and develop and pilot evaluation tools and methods prior to the start of the UH3 phase of the trial, which will be a larger trial. Objectives will be updated for the UH3 phase once awarded.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- First submitted
- 5 Feb 2026
- Start date
- 15 Mar 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- Kaiser Permanente
- Diseases
- Thyroid cancer, Melanoma, Endometrial cancer, Cervical cancer, Colorectal cancer, Ovarian cancer, Sarcoma
- NCT number
- NCT07406087
What you commit to
- Study type: Interventional
- Planned participants: 25
- From 15 Mar 2026 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with a history of or current diagnosis of leukemia or lymphoma
- Patients with metastatic disease at diagnosis
Who the study is looking for
- Received diagnosis of local or regional breast, ovarian, cervical, testicular, colon/rectal, melanoma, endometrial, sarcoma, or thyroid cancer between the ages of 15-39 years ("index cancer")
- Current age 21-45 years
- Diagnosed and treated for index cancer within Kaiser Permanente Southern California adult medical oncology and/or surgery
- Current Kaiser Permanente insurance coverage
Age in the registry: 21 years to 45 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| KP Southern California - Department of Research & Evaluation Coordinator of this site? Confirm its status | Pasadena | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.